J Vet Sci.  2008 Sep;9(3):295-300. 10.4142/jvs.2008.9.3.295.

Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain

Affiliations
  • 1Avian Disease Division, National Veterinary Research Institute, National Veterinary Research and Quarantine Service, Anyang 430-824, Korea. choiks@nvrqs.go.kr

Abstract

Despite the intensive vaccination policy that has been put in place to control Newcastle disease virus (NDV), the recent emergence of NDV genotype VII strains in Korea has led to significant economic losses in the poultry industry. We ssessed the ability of inactivated, oil-emulsion vaccines derived from La Sota or Ulster 2C NDV strains to protect chickens from challenge with Kr-005/00, which is a recently isolated Korean epizootic genotype VII strain. Six-week-old SPF chickens were vaccinated once and challenged three weeks later via the eye drop/intranasal route. All vaccinated birds were fully protected from disease, regardless of the vaccine strains used. All vaccinated and challenged groups showed significant sero-conversion 14 days after challenge. However, some vaccinated birds, despite being protected from disease, shed the challenge virus from their oro-pharynx and cloaca, albeit at significantly lower titers than the unvaccinated challenged control birds. The virological, serological, and epidemiological significance of our observations with regard to NDV disease eradication is discussed.

Keyword

Newcastle disease; protection; vaccination; virus shedding

MeSH Terms

Administration, Intranasal
Animals
Chickens
Cloaca/virology
Disease Outbreaks/prevention & control/*veterinary
Korea
Newcastle Disease/*immunology/prevention & control
Newcastle disease virus/*immunology
Ophthalmic Solutions
Poultry Diseases/*immunology/prevention & control
*Vaccines, Inactivated/administration & dosage
Viral Vaccines/*administration & dosage
Virus Shedding/drug effects

Figure

  • Fig. 1 Titers of Newcastle disease virus recovered from oro-pharyngeal and cloacal swabs after SPF chickens that had been vaccinated with La Sota- or Ulster 2C-derived vaccines were challenged with Kr-005/00 (A) or Kr-KJW/49 (B). OP; oropharyngeal swab, CL; cloacal swab.


Cited by  2 articles

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV
Kiarash Roohani, Sheau Wei Tan, Swee Keong Yeap, Aini Ideris, Mohd Hair Bejo, Abdul Rahman Omar
J Vet Sci. 2015;16(4):447-457.    doi: 10.4142/jvs.2015.16.4.447.

Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein
Satish S. Gaikwad, Hyun-Jeong Lee, Ji-Ye Kim, Kang-Seuk Choi
Clin Exp Vaccine Res. 2019;8(1):27-34.    doi: 10.7774/cevr.2019.8.1.27.


Reference

1. Alexander DJ. Newcastle Disease. 1988. Boston: Kluwer Academic Publishers;147–160.
2. Ballagi-Pordány A, Wehmann E, Herczeg J, Belák S, Lomniczi B. Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch Virol. 1996. 141:243–261.
Article
3. Boursnell ME, Green PF, Samson AC, Campbell JI, Deuter A, Peters RW, Millar NS, Emmerson PT, Binns MM. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology. 1990. 178:297–300.
Article
4. Cho SH, Kim SJ, Kwon HJ. Genomic sequence of an antigenic variant Newcastle disease virus isolated in Korea. Virus Genes. 2007. 35:293–302.
Article
5. Heckert RA, Riva J, Cook S, McMillen J, Schwartz RD. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis. 1996. 40:770–777.
Article
6. Herczeg J, Wehmann E, Bragg RR, Travassos Dias PM, Hadjiev G, Werner O, Lomniczi B. Two novel genetic groups (VIIb and VIII) responsible for recent Newcastle disease outbreaks in Southern Africa, one (VIIb) of which reached Southern Europe. Arch Virol. 1999. 144:2087–2099.
Article
7. Kapczynski DR, King DJ. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine. 2005. 23:3424–3433.
Article
8. Ke GM, Liu HJ, Lin MY, Chen JH, Tsai SS, Chang PC. Molecular characterization of Newcastle disease viruses isolated from recent outbreaks in Taiwan. J Virol Methods. 2001. 97:1–11.
Article
9. King DJ. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge. Avian Dis. 1999. 43:745–755.
Article
10. Kwon HJ, Cho SH, Ahn YJ, Seo SH, Choi KS, Kim SJ. Molecular epidemiology of Newcastle disease in Republic of Korea. Vet Microbiol. 2003. 95:39–48.
Article
11. Lee YJ, Sung HW, Choi JG, Kim JH, Song CS. Molecular epidemiology of Newcastle disease viruses isolated in South Korea using sequencing of the fusion protein cleavage site region and phylogenetic relationships. Avian Pathol. 2004. 33:482–491.
Article
12. Letellier C, Burny A, Meulemans G. Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch Virol. 1991. 118:43–56.
Article
13. Liang R, Cao DJ, Li JQ, Chen J, Guo X, Zhuang FF, Duan MX. Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII. Vet Microbiol. 2002. 87:193–203.
Article
14. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB. Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch Virol. 2003. 148:1387–1403.
Article
15. Loke CF, Omar AR, Raha AR, Yusoff K. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol. 2005. 106:259–267.
Article
16. Mase M, Imai K, Sanada Y, Sanada N, Yuasa N, Imada T, Tsukamoto K, Yamaguchi S. Phylogenetic analysis of Newcastle disease virus genotypes isolated in Japan. J Clin Microbiol. 2002. 40:3826–3830.
Article
17. Mayo MA. A summary of taxonomic changes recently approved by ICTV. Arch Virol. 2002. 147:1655–1663.
Article
18. Peeters BP, de Leeuw OS, Verstegen I, Koch G, Gielkens AL. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine. 2001. 19:1616–1627.
Article
19. Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine. 1996. 14:747–752.
Article
20. Tsai HJ, Chang KH, Tseng CH, Frost KM, Manvell RJ, Alexander DJ. Antigenic and genotypical characterization of Newcastle disease viruses isolated in Taiwan between 1969 and 1996. Vet Microbiol. 2004. 104:19–30.
Article
21. Yang CY, Shieh HK, Lin YL, Chang PC. Newcastle disease virus isolated from recent outbreaks in Taiwan phylogenetically related to viruses (genotype VII) from recent outbreaks in western Europe. Avian Dis. 1999. 43:125–130.
Article
22. Yu L, Wang Z, Jiang Y, Chang L, Kwang J. Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol. 2001. 39:3512–3519.
Article
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr